Clovis Oncology Reports Preliminary Fourth Quarter Sales of Rubraca and Sells Additional SharesThe Motley Fool • 01/07/20
Clovis (CLVS) Up 122.5% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/07/19
Clovis Oncology, Inc. (CLVS) Shares March Higher, Can It Continue?Zacks Investment Research • 11/29/19
Clovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/07/19
Analysts Estimate Clovis Oncology (CLVS) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/31/19